Co-Authors
This is a "connection" page, showing publications co-authored by DIANE C BODURKA and KAREN M BASEN-ENGQUIST.
Connection Strength
1.076
-
Cervical cancer. Cancer. 2003 Nov 01; 98(9 Suppl):2009-14.
Score: 0.242
-
Reliability and validity of the functional assessment of cancer therapy-ovarian. J Clin Oncol. 2001 Mar 15; 19(6):1809-17.
Score: 0.202
-
Comparison of four brief depression screening instruments in ovarian cancer patients: Diagnostic accuracy using traditional versus alternative cutpoints. Gynecol Oncol. 2017 06; 145(3):562-568.
Score: 0.154
-
Social-cognitive theory predictors of exercise behavior in endometrial cancer survivors. Health Psychol. 2013 Nov; 32(11):1137-48.
Score: 0.115
-
Associations with worry about dying and hopelessness in ambulatory ovarian cancer patients. Palliat Support Care. 2009 Sep; 7(3):299-306.
Score: 0.091
-
Physical activity and obesity in endometrial cancer survivors: associations with pain, fatigue, and physical functioning. Am J Obstet Gynecol. 2009 Mar; 200(3):288.e1-8.
Score: 0.086
-
Predictors of sexual functioning in ovarian cancer patients. J Clin Oncol. 2004 Mar 01; 22(5):881-9.
Score: 0.062
-
Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol Oncol. 2000 Sep; 78(3 Pt 1):302-8.
Score: 0.049
-
Use of social media to conduct a cross-sectional epidemiologic and quality of life survey of patients with neuroendocrine carcinoma of the cervix: a feasibility study. Gynecol Oncol. 2014 Jan; 132(1):149-53.
Score: 0.030
-
Approaches for end-of-life care in the field of gynecologic oncology: an exploratory study. Int J Gynecol Cancer. 2004 Jul-Aug; 14(4):580-8.
Score: 0.016
-
An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol. 2004 Feb 15; 22(4):671-7.
Score: 0.015
-
Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time? Gynecol Oncol. 2002 Oct; 87(1):118-28.
Score: 0.014